Home » Topics » Regulatory

Regulatory
RSS

Diatide receives second major product approval in less than 12 months

Aug. 5, 1999

FDA approves Antagon for LH inhibition in women undergoing fertility treatment

July 30, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

FDA approves SB's Kytril for prevention of radiation-induced nausea and vomiting

July 29, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

FDA approves pediatric formulation of Topamax

July 28, 1999

Fujisawa initiates enrollment in phase III RA trial of Prograf

July 27, 1999

OraSolv Zomig receives first regulatory approval in Sweden for migraine

July 22, 1999

Tachykinin antagonists now proposed for attention deficit disorders

July 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...